MANASSAS, VA. (PRWEB) DECEMBER 01, 2021 The ongoing COVID-19 pandemic ranks as perhaps the most serious global health crisis of the past hundred years. Worldwide,
Source: Pharmaceutical Outsourcing The outbreak of the COVID-19 pandemic seriously disrupted new drug testing, treatments, and in-person healthcare services; access to clinical trial sites was
Serious inefficiencies are hampering clinical trials of new drugs and treatments, prolonging the suffering of millions. Today’s platform technologies, says Dr. Harsha Rajasimha of Jeeva
Source: eurweb.com Did you know that 80% of participants of randomized, controlled clinical trials are Caucasian males or that less than 10% of those trials
Clinical trials of new drugs and treatments have a high failure rate. Better planning and technology-aided communication, says Dr. Harsha Rajasimha of Jeeva Trials, can
Over the last two years, testing of new drugs, medical devices, and vaccines has increasingly been done outside large medical centers. To benefit both sponsors
Source: Medium In recent years, Big Tech has gotten a bad rep. But of course many tech companies are doing important work making monumental positive
Source: The Hill Black, Indigenous and other Americans of color are being left out of vital medical developments, including those targeting diseases and conditions that
Patient test groups for new drugs and treatments, notes Dr. Harsha Rajasimha of Jeeva Trials, tend to be non-diverse. However, recently developed digital health technologies
By: Harsha K. Rajasimha, MS, PhD & Sharlene Brown, PhD Clinical trials are the regulatory mechanisms agencies like the Food and Drug Administration (FDA) use
Jeeva Clinical Trials Inc.
